Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 2
2010 5
2011 7
2012 5
2013 5
2014 3
2015 2
2016 6
2017 3
2018 6
2019 4
2020 7
2021 12
2022 6
2023 14
2024 29
2025 33
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
A creeping eruption.
De Luca E, Pellegrino L, Caldarola G. De Luca E, et al. Among authors: caldarola g. JAAD Case Rep. 2024 Nov 16;56:54-56. doi: 10.1016/j.jdcr.2024.10.025. eCollection 2025 Feb. JAAD Case Rep. 2024. PMID: 39845464 Free PMC article. No abstract available.
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study.
Balestri R, Odorici G, Magnano M, Gisondi P, Bellinato F, Ribero S, Dapavo P, Mastorino L, Burlando M, Cozzani E, Bernardini N, Potenza C, Balato A, Caccavale S, Di Lernia V, Peccerillo F, Megna M, Campanati A, Loconsole F, Mortato E, Trovato E, Mantovani L, Caldarola G, De Simone C, Falco GM, Narcisi A, Alfano A, Galluzzo M, Fico A, Pezzolo E, Prignano F, Di Cesare A, Loi C, Satolli F, Musumeci ML, Ortega R, Errichetti E, Dini V, Michelucci A, Amerio P, Carugno A, Tabanelli M, Conti A, Guarneri C, Bardazzi F, Rech G. Balestri R, et al. Among authors: caldarola g. J Eur Acad Dermatol Venereol. 2026 Jan;40(1):e48-e51. doi: 10.1111/jdv.20774. Epub 2025 May 29. J Eur Acad Dermatol Venereol. 2026. PMID: 40439441 No abstract available.
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis).
Esposito M, Gisondi P, Assorgi C, Bellinato F, Brianti P, Burlando M, Brunasso G, Caccavale S, Caldarola G, Campione E, Calzavara Pinton P, Campanati A, Carrera CG, Carugno A, Cozzani E, Costanzo A, Cusano F, Dapavo P, Dattola A, De Simone C, Di Caprio R, Diotallevi F, Fargnoli MC, Gaiani F, Giunta A, Malagoli P, Marzano AV, Megna M, Mercuri SR, Mortato E, Narcisi A, Orsini D, Potestio L, Quaglino P, Richetta AG, Romano F, Sena P, Vagnozzi E, Venturini M, Loconsole F, Balato A. Esposito M, et al. Among authors: caldarola g. Clin Drug Investig. 2025 Jun;45(6):309-315. doi: 10.1007/s40261-025-01440-z. Epub 2025 May 15. Clin Drug Investig. 2025. PMID: 40372625 Free PMC article. No abstract available.
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?
Mortato E, Gori N, Caldarola G, Talamonti M, Paganini C, Boeti L, Russo F, Grieco T, Tolino E, Moretta G, Pigliacelli F, Coppola R, Giordano D, Chello C, Potenza C, Fargnoli MC, Panasiti V, Cocuroccia B, Peris K, Galluzzo M. Mortato E, et al. Among authors: caldarola g. J Dermatolog Treat. 2025 Dec;36(1):2509541. doi: 10.1080/09546634.2025.2509541. Epub 2025 Jun 9. J Dermatolog Treat. 2025. PMID: 40485504 Free article.
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results.
Piraccini BM, Cedirian S, Pampaloni F, Rapparini L, Quadrelli F, Bruni F, Ala L, Acri MC, Rossi A, Pellacani G, Lacarrubba F, Dall'Oglio F, Micali G, Foggia L, Cantelli M, Nappa P, Diluvio L, Bianchi L, Luigi N, Bolzon A, Peris K, Caldarola G, Girolomoni G, Marangoni F, Bellinato F, Gisondi P, Silvi G, Prignano F, Pimpinelli N, Tomasini C, Barruscotti S, Simonetti O, de Simoni E, Ambrogio F, Foti C, Boccaletti V, Fraghì A, Marzano AV, Mattioli MA, Ferrucci S, Sechi A, Valtellini L, Barbareschi M, Gallo G, Ribero S, Quaglino P, Di Corteranzo IG, Balestri R, Pagliarello C, Caposiena RD, Zalaudek I, Vagnozzi E, Fargnoli MC, Caponio C, Rubegni P, Cinotti E, Trovato E, Romanelli M, Dini V, Manzo Margiotta F, Feliciani C, De Felici Del Giudice MB, Atzori L, Sanna S, Lembo S, Raimondo A, Magnano M, Argenziano G, Babino G, Fulgione E, Rongioletti F, Pesce N, Guida S, Guglielmo A, Schettini N, Starace M. Piraccini BM, et al. Among authors: caldarola g. J Eur Acad Dermatol Venereol. 2026 Feb;40(2):224-231. doi: 10.1111/jdv.70067. Epub 2025 Sep 23. J Eur Acad Dermatol Venereol. 2026. PMID: 40985491
A long-term real-world safety study of guselkumab in patients with psoriasis who have infectious comorbidities, malignancies or heart disease: the EARLY study.
Mortato E, Talamonti M, Marcelli L, Megna M, Raimondo A, Caldarola G, Bernardini N, Balato A, Campanati A, Esposito M, Bonifati C, Lora V, Potestio L, Lembo S, Loconsole F, De Luca E, Skroza N, Buononato D, Bianchelli T, Fargnoli MC, Tommasino N, Primavera F, De Simone C, Bianchi L, Galluzzo M. Mortato E, et al. Among authors: caldarola g. Clin Exp Dermatol. 2025 Aug 22;50(9):1786-1794. doi: 10.1093/ced/llaf172. Clin Exp Dermatol. 2025. PMID: 40238960
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study.
Mortato E, Talamonti M, Marcelli L, Megna M, Raimondo A, Caldarola G, Bernardini N, Balato A, Campanati A, Esposito M, Bonifati C, Lora V, Potestio L, Lembo S, Loconsole F, De Luca E, Skroza N, Buononato D, Bianchelli T, Fargnoli MC, Tommasino N, Primavera F, De Simone C, Bianchi L, Galluzzo M. Mortato E, et al. Among authors: caldarola g. Dermatol Ther (Heidelb). 2025 May;15(5):1239-1250. doi: 10.1007/s13555-025-01394-2. Epub 2025 Apr 16. Dermatol Ther (Heidelb). 2025. PMID: 40238056 Free PMC article.
Evaluation of Upadacitinib Efficacy in the Treatment of Atopic Dermatitis of Sensitive Areas.
Gori N, Galluzzo M, Chiricozzi A, Grieco T, Chello C, Russo F, Tolino E, Pigliacelli F, Mazzotta AM, Talamonti M, Paganini C, Caldarola G, Cocuroccia B, Antonelli F, Boeti L, Giordano D, Bianchi L, De Simone C, Pellacani G, Peris K. Gori N, et al. Among authors: caldarola g. Dermatology. 2025;241(3):223-229. doi: 10.1159/000545227. Epub 2025 Apr 23. Dermatology. 2025. PMID: 40267900
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study.
Dattola A, Bernardini N, Svara F, Balato A, Caldarola G, D'Amico D, De Simone C, Di Brizzi EV, Esposito M, Giofrè C, Giordano D, Guarneri C, Loconsole F, Lora V, Moretta G, Orsini D, Persechino S, Potenza C, Ragonesi S, Pellacani G, Peris K, Fargnoli MC, Richetta AG. Dattola A, et al. Among authors: caldarola g. J Dermatolog Treat. 2024 Dec;35(1):2420825. doi: 10.1080/09546634.2024.2420825. Epub 2024 Oct 27. J Dermatolog Treat. 2024. PMID: 39462515 Free article.
138 results